Condition (MeSH)
Aortitis
ClinicalTrials.gov lists 6 trials for Aortitis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
6 of the 6 trials are tagged with Aortitis itself; the rest are tagged with a narrower condition beneath it.
When did Aortitis trials start? (6)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 4
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2022 | 1 |
| 2017 | 1 |
| 2016 | 1 |
| 2015 | 1 |
| 2010 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 6 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Aortitis trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 4 | 1 |
| Observational | 5 |
How many Aortitis trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 3 |
| Completed | 2 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Aortitis? (15)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. | Annals of the rheumatic diseases | 2019 | Yes |
| Arterial inflammation measured by <sup>18</sup>F-FDG-PET-CT to predict coronary events in older subjects. | Atherosclerosis | 2018 | Yes |
| Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study. | European journal of internal medicine | 2018 | Yes |
| Aortitis due to giant cell arteritis and psoriatic arthritis: An uncommon association. | Reumatologia clinica | 2017 | Yes |
| Thresholds for Arterial Wall Inflammation Quantified by <sup>18</sup>F-FDG PET Imaging: Implications for Vascular Interventional Studies. | JACC. Cardiovascular imaging | 2016 | Yes |
Showing 5 of 15 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.